ONE NUCLEUS STRENGTHENS BOARD WITH APPOINTMENT OF NEW DIRECTOR

Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024

Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
An advanced two-day programme for in-house counsel: navigating law, incident response and frontline intelligence
Developed and delivered jointly by Mandiant’s (part of Google Cloud) world‑leading incident response and threat intelligence experts together with senior legal specialists from Marks & Clerk, this two‑day advanced programme provides an academic‑grade, practice‑oriented training experience for in‑house lawyers, general counsel, risk leaders and compliance professionals.
The LSX Investival Showcase is your gateway to biopharma and medtech investment and partnering.
Taking place on the first day of London Life Science Week, it's growing in size and scale. It's the first and biggest public event of the week, open to the wider life science community, and offers full partnering facilities to all attendees.
*One Nucleus members receive 15% discount off registration. Please email [email protected] for the discount code
We are seeking a confident and experienced scientist with a strong biophysics background to join a fast-growing drug discovery services company based on Milton Park in Abingdon, Oxfordshire. The successful candidate will play a crucial role in all aspects of both our client-focused work and collaborative discovery projects, applying quantitative and biophysical approaches to advance our drug discovery programmes.
Main Responsibilties
Now in its fourth year, Asia Bio Partnering Forum will unite over 650 innovators from major Asian markets with global life science leaders to foster dealmaking and collaboration across the region.
*One Nucleus Members receive 15% off registration - please email [email protected] for the code
Cambridge UK: 22 June 2026
![]() |
|
The Francis Crick Institute and Medicines Discovery Catapult (MDC) have today opened applications for the ninth cohort of KQ Labs, a national accelerator for data-driven health start-ups.
Delivered by the Francis Crick Institute, with ongoing support from MDC and Cancer Research Horizons, KQ Labs is an annual five-month programme for early-stage companies building science-backed, scalable solutions in AI-driven drug discovery, digital health, and precision medicine.

by Philippa Clark, Director of Business Development, One Nucleus
Capital efficiency is one of those topics that seems to come up everywhere at the moment. It’s discussed on panels, debated in investor meetings and frequently raised in networking conversations, yet despite how often we hear the term, I was curious to explore what it really means in practice.
by Alicia Gailliez, Business Development Manager, One Nucleus
